PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392048
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392048
Anti-Radiation Drugs Market, By Indication, By Route of Administration, By Distribution Channel, By Geography
Global Anti-Radiation Drugs Market size is expected to be valued at US$ 587.4 Mn in 2023, and is expected to reach US$ 931 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 587.4 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 6.80% | 2030 Value Projection: | US$ 931 Mn |
Anti-radiation drugs are pharmaceutical medications that are used to combat the harmful effects of radiation exposure in humans. Prolonged exposure to ionizing radiation can have detrimental effects on the body that leads to various health issues such as radiation sickness, cancer, and genetic mutations, and this has boosted demand for anti-radiation drugs in recent years.
These drugs work by protecting the body's cells and DNA from the damaging effects of radiation. These aid in reducing the risk of radiation-induced illnesses and improving the chances of survival for individuals exposed to radiation. Anti-radiation drugs can be used as preventive measures for people working in industries that involve radiation exposure, as well as for individuals in areas prone to natural radiation.
Market Dynamics:
Global anti-radiation drugs market is projected to witness significant growth in the near future. The market growth is driven by increasing prevalence of cancer and growing adoption of radiation therapy in cancer treatment. Rising number of nuclear power plants, along with the potential risk of radiation leaks, further boosts demand for anti-radiation drugs.
There are certain factors that may restrain the market growth. These include the high cost of anti-radiation drugs and the stringent regulatory requirements for drug approval. Moreover, the lack of awareness about the availability and benefits of these drugs among healthcare professionals and the general population could hinder market growth.
Despite the challenges, the market presents numerous opportunities for growth. Increasing investment in research and development activities to develop new and improved anti-radiation drugs expected to offer opportunity to the market. Rising demand for personalized medicine and growing focus on precision healthcare are expected to drive the market growth.
Key Features of the Study:
- This report provides in-depth analysis of the global anti-radiation drugs market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
- It elucidates potential revenue opportunities across different market segments and explains attractive investment propositions
- The study provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and the competitive strategies adopted by key players
- Key players in the global anti-radiation drugs market are profiled based on parameters such as company highlights, product portfolio, financial performance, and strategies
- The report includes prominent companies such as Amgen Inc., Partner Therapeutics Inc., RedHill Biopharma Ltd., Humanetics Corporation, RxBio Inc., Soligenix Inc., Aeolus Pharmaceuticals, Onconova Therapeutics, and Genome Protection Inc.
- Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
- The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders can benefit from the various strategy matrices used in analyzing the global anti-radiation drugs market, facilitating ease in decision-making
Anti-Radiation Drugs Market Detailed Segmentation:
- By Indication
- Acute Radiation Syndrome
- Delayed Radiation Syndrome
- By Route of Administration
- Oral
- Intramuscular
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Amgen Inc.
- Partner Therapeutics Inc.
- RedHill Biopharma Ltd.
- Humanetics Corporation
- RxBio Inc.
- Soligenix Inc.
- Aeolus Pharmaceuticals
- Onconova Therapeutics
- Genome Protection Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing incidence of cancer globally
- Growing threat of nuclear accidents and events
- Favorable regulatory environment for drug development
- Technological advancements in drug delivery systems
- Restraints
- Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Anti-Radiation Drugs Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Anti-Radiation Drugs Market, By Indication, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Acute Radiation Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Delayed Radiation Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Global Anti-Radiation Drugs Market, By Route of Administration, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Global Anti-Radiation Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Anti-Radiation Drugs Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Partner Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- RedHill Biopharma Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Humanetics Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- RxBio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Soligenix Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aeolus Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Onconova Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genome Protection Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
